A second extracellular site is required for norepinephrine transport by the human norepinephrine transporter

Molecular Pharmacology

Volumn 82, Issue 5, 2012, Pages 898-909

  Wang, Ching I A ^a   Shaikh, Nausad H ^a   Ramu, Soumya ^a   Lewis, Richard J ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; NISOXETINE; NORADRENALIN TRANSPORTER;

ARTICLE; BINDING AFFINITY; BINDING SITE; DRUG BINDING; DRUG DETERMINATION; DRUG TRANSPORT; EXTRACELLULAR SPACE; MOLECULAR DOCKING; MUTATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN STRUCTURE; SIMULATION;

ADRENERGIC UPTAKE INHIBITORS; ANIMALS; BINDING SITES; BIOLOGICAL TRANSPORT; CERCOPITHECUS AETHIOPS; COMPUTER SIMULATION; COS CELLS; FLUOXETINE; HUMANS; LEUCINE; MOLECULAR DOCKING SIMULATION; MUTAGENESIS, SITE-DIRECTED; NOREPINEPHRINE; NOREPINEPHRINE PLASMA MEMBRANE TRANSPORT PROTEINS;

EID: 84867788881     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.112.080630     Document Type: Article

References (66)

1. Amara SG and Sonders MS (1998) Neurotransmitter transporters as molecular targets for addictive drugs. Drug Alcohol Depend 51:87-96. (Pubitemid 28353758)
2. Andersen J, Kristensen AS, Bang-Andersen B, and Stromgaard K (2009) Recent advances in the understanding of the interaction of antidepressant drugs with serotonin and norepinephrine transporters. Chem Commun (Camb) 25:3677-3692.
3. Barker EL, Moore KR, Rakhshan F, and Blakely RD (1999) Transmembrane domain I contributes to the permeation pathway for serotonin and ions in the serotonin transporter. J Neurosci 19:4705-4717. (Pubitemid 29270106)
4. Beuming T, Kniazeff J, Bergmann ML, Shi L, Gracia L, Raniszewska K, Newman AH, Javitch JA, Weinstein H, Gether U, et al. (2008) The binding sites for cocaine and dopamine in the dopamine transporter overlap. Nat Neurosci 11:780-789.
5. + symporters (NSS) aids in the use of the LeuT structure to probe NSS structure and function. Mol Pharmacol 70:1630-1642.
6. Bowie JU, Lüthy R, and Eisenberg D (1991) A method to identify protein sequences that fold into a known three-dimensional structure. Science 253:164-170. (Pubitemid 21917131)
7. Brust A, Palant E, Croker DE, Colless B, Drinkwater R, Patterson B, Schroeder CI, Wilson D, Nielsen CK, Smith MT, et al. (2009) chi-Conopeptide pharmacophore development: toward a novel class of norepinephrine transporter inhibitor (Xen2174) for pain. J Med Chem 52:6991-7002.
8. Buck KJ and Amara SG (1994) Chimeric dopamine-norepinephrine transporters delineate structural domains influencing selectivity for catecholamines and 1-methyl-4-phenylpyridinium. Proc Natl Acad Sci USA 91:12584-12588.
9. Carboni E and Silvagni A (2004) Dopamine reuptake by norepinephrine neurons: exception or rule? Crit Rev Neurobiol 16:121-128. (Pubitemid 39586910)
10. Chen J, Lu G, Lin J, Davidson AL, and Quiocho FA (2003) A tweezers-like motion of the ATP-binding cassette dimer in an ABC transport cycle. Mol Cell 12:651-661. (Pubitemid 37222486)
11. Chen NH, Reith ME, and Quick MW (2004) Synaptic uptake and beyond: the sodium- and chloride-dependent neurotransmitter transporter family SLC6. Pflugers Arch 447:519-531. (Pubitemid 38241438)
12. Dougherty DD, Bonab AA, Spencer TJ, Rauch SL, Madras BK, and Fischman AJ (1999) Dopamine transporter density in patients with attention deficit hyperactivity disorder. Lancet 354:2132-2133. (Pubitemid 30008900)
13. Emsley P and Cowtan K (2004) Coot: model-building tools for molecular graphics. Acta Crystallogr D Biol Crystallogr 60:2126-2132. (Pubitemid 41742764)
14. Erreger K, Grewer C, Javitch JA, and Galli A (2008) Currents in response to rapid concentration jumps of amphetamine uncover novel aspects of human dopamine transporter function. J Neurosci 28:976-989. (Pubitemid 351158997)
15. Fiser A and Sali A (2003) Modeller: generation and refinement of homology-based protein structure models. Methods Enzymol 374:461-491. (Pubitemid 37531821)
16. Forrest LR, Tang CL, and Honig B (2006) On the accuracy of homology modeling and sequence alignment methods applied to membrane proteins. Biophys J 91:508-517.
17. --dependent transporters. Proc Natl Acad Sci USA 104:12761-12766.
18. Forrest LR, Zhang YW, Jacobs MT, Gesmonde J, Xie L, Honig BH, and Rudnick G (2008) Mechanism for alternating access in neurotransmitter transporters. Proc Natl Acad Sci USA 105:10338-10343.
19. Gunsteren WF von and Berendsen HJC (1990) Computer simulation of molecular dynamics: methodology, applications, and perspectives in chemistry. Angew Chem Int Ed Eng 29:992-1023.
20. Hahn MK, Robertson D, and Blakely RD (2003) A mutation in the human norepinephrine transporter gene (SLC6A2) associated with orthostatic intolerance disrupts surface expression of mutant and wild-type transporters. J Neurosci 23:4470-4478. (Pubitemid 36706177)
21. Henry LK, Defelice LJ, and Blakely RD (2006) Getting the message across: a recent transporter structure shows the way. Neuron 49:791-796. (Pubitemid 43376076)
22. Huang X and Zhan CG (2007) How dopamine transporter interacts with dopamine: insights from molecular modeling and simulation. Biophys J 93:3627-3639. (Pubitemid 350190825)
23. Indarte M, Madura JD, and Surratt CK (2008) Dopamine transporter comparative molecular modeling and binding site prediction using the LeuT(Aa) leucine transporter as a template. Proteins 70:1033-1046. (Pubitemid 351161959)
24. Jacobs MT, Zhang YW, Campbell SD, and Rudnick G (2007) Ibogaine, a noncompetitive inhibitor of serotonin transport, acts by stabilizing the cytoplasm-facing state of the transporter. J Biol Chem 282:29441-29447. (Pubitemid 350043359)
25. Jayanthi LD, Prasad PD, Ramamoorthy S, Mahesh VB, Leibach FH, and Ganapathy V (1993) Sodium- and chloride-dependent, cocaine-sensitive, high-affinity binding of nisoxetine to the human placental norepinephrine transporter. Biochemistry 32:12178-12185. (Pubitemid 23353658)
26. 123I]-β-CIT demonstrates presynaptic nigrostriatal dopaminergic damage in Wilson's disease. J Neurol Neurosurg Psychiatry 65:60-64.
27. 2+ inhibits glycine transport by glycine transporter subtype 1b. J Biol Chem 279:22983-22991.
28. Kelley LA and Sternberg MJ (2009) Protein structure prediction on the Web: a case study using the Phyre server. Nat Protoc 4:363-371.
29. 123-IPT in normal and Parkinson's disease subjects. J Nucl Med 38:1703-1711.
30. Klimek V, Stockmeier C, Overholser J, Meltzer HY, Kalka S, Dilley G, and Ordway GA (1997) Reduced levels of norepinephrine transporters in the locus coeruleus in major depression. J Neurosci 17:8451-8458.
31. Krishnamurthy H and Gouaux E (2012) X-ray structures of LeuT in substrate-free outward-open and apo inward-open states. Nature 481:469-474.
32. Krishnamurthy H, Piscitelli CL, and Gouaux E (2009) Unlocking the molecular secrets of sodium-coupled transporters. Nature 459:347-355.
33. Krogh A, Larsson B, von Heijne G, and Sonnhammer EL (2001) Predicting transmembrane protein topology with a hidden Markov model: application to complete genomes. J Mol Biol 305:567-580. (Pubitemid 33032862)
34. Larkin MA, Blackshields G, Brown NP, Chenna R, McGettigan PA, McWilliam H, Valentin F, Wallace IM, Wilm A, Lopez R, et al. (2007) Clustal W and Clustal X version 2. Bioinformatics 23:2947-2948.
35. Laskowski RA, Watson JD, and Thornton JM (2005) ProFunc: a server for predicting protein function from 3D structure. Nucleic Acids Res 33:W89-W93. (Pubitemid 44529886)
36. Masson J, Sagné C, Hamon M, and El Mestikawy S (1999) Neurotransmitter transporters in the central nervous system. Pharmacol Rev 51:439-464. (Pubitemid 29420211)
37. Mitchell SM, Lee E, Garcia ML, and Stephan MM (2004) Structure and function of extracellular loop 4 of the serotonin transporter as revealed by cysteine-scanning mutagenesis. J Biol Chem 279:24089-24099. (Pubitemid 38725268)
38. Nielsen CK, Lewis RJ, Alewood D, Drinkwater R, Palant E, Patterson M, Yaksh TL, McCumber D, and Smith MT (2005) Anti-allodynic efficacy of the chi-conopeptide, Xen2174, in rats with neuropathic pain. Pain 118:112-124. (Pubitemid 41566590)
39. Norregaard L, Frederiksen D, Nielsen EO, and Gether U (1998) Delineation of an endogenous zinc-binding site in the human dopamine transporter. EMBO J 17:4266-4273. (Pubitemid 28362617)
40. Paczkowski FA, Sharpe IA, Dutertre S, and Lewis RJ (2007) chi-Conotoxin and tricyclic antidepressant interactions at the norepinephrine transporter define a new transporter model. J Biol Chem 282:17837-17844. (Pubitemid 47100310)
41. Piscitelli CL, Krishnamurthy H, and Gouaux E (2010) Neurotransmitter/ sodium symporter orthologue LeuT has a single high-affinity substrate site. Nature 468:1129-1132.
42. Quick M, Shi L, Zehnpfennig B, Weinstein H, and Javitch JA (2012) Experimental conditions can obscure the second high-affinity site in LeuT. Nat Struct Mol Biol 19:207-211.
43. Quick M, Winther AM, Shi L, Nissen P, Weinstein H, and Javitch JA (2009) Binding of an octylglucoside detergent molecule in the second substrate (S2) site of LeuT establishes an inhibitor-bound conformation. Proc Natl Acad Sci USA 106:5563-5568.
44. Ritchie DW and Kemp GJ (2000) Protein docking using spherical polar Fourier correlations. Proteins 39:178-194. (Pubitemid 30176485)
45. Ritz MC, Lamb RJ, Goldberg SR, and Kuhar MJ (1987) Cocaine receptors on dopamine transporters are related to self-administration of cocaine. Science 237:1219-1223. (Pubitemid 17131228)
46. Rudnick G and Wall SC (1992) The molecular mechanism of "ecstasy" [3,4-methylenedioxy-methamphetamine (MDMA)]: serotonin transporters are targets for MDMA-induced serotonin release. Proc Natl Acad Sci USA 89:1817-1821.
47. 1-adrenoceptor and noradrenaline transporter. Nat Neurosci 4:902-907.
48. + and substrate is triggered by substrate in a second binding site. Mol Cell 30:667-677.
49. Singh SK, Piscitelli CL, Yamashita A, and Gouaux E (2008) A competitive inhibitor traps LeuT in an open-to-out conformation. Science 322:1655-1661.
50. Singh SK, Yamashita A, and Gouaux E (2007) Antidepressant binding site in a bacterial homologue of neurotransmitter transporters. Nature 448:952-956. (Pubitemid 47312772)
51. Sinning S, Musgaard M, Jensen M, Severinsen K, Celik L, Koldsø H, Meyer T, Bols M, Jensen HH, Schiøtt B, et al. (2010) Binding and orientation of tricyclic antidepressants within the central substrate site of the human serotonin transporter. J Biol Chem 285:8363-8374.
52. Smicun Y, Campbell SD, Chen MA, Gu H, and Rudnick G (1999) The role of external loop regions in serotonin transport. Loop scanning mutagenesis of the serotonin transporter external domain. J Biol Chem 274:36058-36064.
53. Stephan MM, Chen MA, Penado KM, and Rudnick G (1997) An extracellular loop region of the serotonin transporter may be involved in the translocation mechanism. Biochemistry 36:1322-1328.
54. Tang L, Bai L, Wang WH, and Jiang T (2010) Crystal structure of the carnitine transporter and insights into the antiport mechanism. Nat Struct Mol Biol 17:492-496.
55. Tavoulari S, Forrest LR, and Rudnick G (2009) Fluoxetine (Prozac) binding to serotonin transporter is modulated by chloride and conformational changes. J Neurosci 29:9635-9643.
56. Trott O and Olson AJ (2010) AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem 31:455-461.
57. Vriend G (1990) WHAT IF: a molecular modeling and drug design program. J Mol Graph 8:52-56, 29.
58. Wang H, Elferich J, and Gouaux E (2012) Structures of LeuT in bicelles define conformation and substrate binding in a membrane-like context. Nat Struct Mol Biol 19:212-219.
59. Wong DF, Harris JC, Naidu S, Yokoi F, Marenco S, Dannals RF, Ravert HT, Yaster M, Evans A, Rousset O, et al. (1996) Dopamine transporters are markedly reduced in Lesch-Nyhan disease in vivo. Proc Natl Acad Sci USA 93:5539-5543. (Pubitemid 26159486)
60. --dependent neurotransmitter transporters. Nature 437:215-223.
61. Zhang YW and Rudnick G (2006) The cytoplasmic substrate permeation pathway of serotonin transporter. J Biol Chem 281:36213-36220.
62. +-coupled neurotransmitter transporter homologue. Nature 474:109-113.
63. Zhou Z, Zhen J, Karpowich NK, Goetz RM, Law CJ, Reith ME, and Wang DN (2007) LeuT-desipramine structure reveals how antidepressants block neurotransmitter reuptake. Science 317:1390-1393. (Pubitemid 47417479)
64. Zhou Z, Zhen J, Karpowich NK, Law CJ, Reith ME, and Wang DN (2009) Antidepressant specificity of serotonin transporter suggested by three LeuT-SSRI structures. Nat Struct Mol Biol 16:652-657.
65. Zomot E, Bendahan A, Quick M, Zhao Y, Javitch JA, and Kanner BI (2007) Mechanism of chloride interaction with neurotransmitter:sodium symporters. Nature 449:726-730. (Pubitemid 47552085)
66. Zomot E and Kanner BI (2003) The interaction of the γ-aminobutyric acid transporter GAT-1 with the neurotransmitter is selectively impaired by sulfhydryl modification of a conformationally sensitive cysteine residue engineered into extracellular loop IV. J Biol Chem 278:42950-42958. (Pubitemid 37345907)